Bausch Health Companies Inc.
BHC
$7.82
-$0.27-3.34%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 8.66B | 8.45B | 8.26B | 8.06B | 8.03B |
| Total Other Revenue | 94.00M | 93.00M | 92.00M | 94.00M | 99.00M |
| Total Revenue | 8.76B | 8.54B | 8.35B | 8.15B | 8.12B |
| Cost of Revenue | 2.56B | 2.51B | 2.47B | 2.40B | 2.36B |
| Gross Profit | 6.20B | 6.04B | 5.88B | 5.76B | 5.76B |
| SG&A Expenses | 2.91B | 2.80B | 2.75B | 2.71B | 2.59B |
| Depreciation & Amortization | 1.08B | 1.11B | 1.15B | 1.18B | 1.22B |
| Other Operating Expenses | 1.00M | 3.00M | 3.00M | 1.00M | 1.00M |
| Total Operating Expenses | 7.15B | 7.01B | 6.94B | 6.83B | 6.70B |
| Operating Income | 1.61B | 1.53B | 1.41B | 1.32B | 1.42B |
| Income Before Tax | -390.00M | -740.00M | 25.00M | -183.00M | -129.00M |
| Income Tax Expenses | 221.00M | 234.00M | 214.00M | 172.00M | 83.00M |
| Earnings from Continuing Operations | -611.00 | -974.00 | -189.00 | -355.00 | -212.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 19.00M | 11.00M | 3.00M | -2.00M | -13.00M |
| Net Income | -592.00M | -963.00M | -186.00M | -357.00M | -225.00M |
| EBIT | 1.61B | 1.53B | 1.41B | 1.32B | 1.42B |
| EBITDA | 2.87B | 2.83B | 2.74B | 2.68B | 2.82B |
| EPS Basic | -1.63 | -2.65 | -0.51 | -0.98 | -0.62 |
| Normalized Basic EPS | 0.50 | 0.43 | 0.15 | -0.15 | -0.10 |
| EPS Diluted | -1.63 | -2.65 | -0.51 | -0.98 | -0.62 |
| Normalized Diluted EPS | 0.50 | 0.43 | 0.15 | -0.15 | -0.10 |
| Average Basic Shares Outstanding | 1.45B | 1.46B | 1.45B | 1.45B | 1.45B |
| Average Diluted Shares Outstanding | 1.45B | 1.46B | 1.46B | 1.45B | 1.45B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
